Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Skeletal Muscle Bioenergetics in Critical Limb Ischemia and Diabetes.

The Journal of surgical research·2023
Same author

Impact of "Defensive Medicine" on the Costs of Diabetes and Associated Conditions.

Annals of vascular surgery·2022
Same author

Surgical and reconstructive outcomes in primary venous leiomyosarcoma.

Journal of vascular surgery. Venous and lymphatic disorders·2021
Same author

Endarterectomy for Iliac Occlusive Disease during Kidney Transplantation: A Multicenter Experience.

The International journal of angiology : official publication of the International College of Angiology, Inc·2021
Same author

Procedure Reimbursement, Inflation, and the Declining Buying Power of the Vascular Surgeon (2011-2021).

Annals of vascular surgery·2021
Same author

Carotid endarterectomy surgeon volumes in contemporary practice: A comparison to randomized trial inclusion criteria.

American journal of surgery·2020
Same journal

A critical analysis of the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) and the European Carotid Surgery Trial (ECST)-2.

Seminars in vascular surgery·2026
Same journal

Operationalizing patient and stakeholder engagement in high-acuity trials: Lessons from IMPROVE-AD.

Seminars in vascular surgery·2026
Same journal

Lost to follow-up: A narrative review of socioeconomic, psychosocial, and systemic barriers to aortic dissection surveillance.

Seminars in vascular surgery·2026
Same journal

Regulatory oversight, innovation, and access in aortic dissection care: The evolving roles of the US Food and Drug Administration and Centers for Medicare & Medicaid Services.

Seminars in vascular surgery·2026
Same journal

What is the best thoracic endovascular aortic repair landing zone for Type B aortic dissection?

Seminars in vascular surgery·2026
Same journal

Role of illicit drug use in Type B aortic dissection and trial participation.

Seminars in vascular surgery·2026
See all related articles

Related Experiment Video

Updated: May 16, 2026

A New Murine Model of Endovascular Aortic Aneurysm Repair
08:51

A New Murine Model of Endovascular Aortic Aneurysm Repair

Published on: July 7, 2013

Inflammatory aneurysms treated with EVAR.

William M Stone1, Grant T Fankhauser

  • 1Mayo Clinic, Phoenix, AZ 85254, USA. stone.william@mayo.edu

Seminars in Vascular Surgery
|December 5, 2012
PubMed
Summary
This summary is machine-generated.

Endovascular aneurysm repair (EVAR) is increasingly used for inflammatory abdominal aortic aneurysms (IAAA). This study supports EVAR for IAAA, showing it is a viable treatment option despite concerns about persistent inflammation.

More Related Videos

Microsurgical Creation of Giant Bifurcation Aneurysms in Rabbits for the Evaluation of Endovascular Devices
07:21

Microsurgical Creation of Giant Bifurcation Aneurysms in Rabbits for the Evaluation of Endovascular Devices

Published on: September 8, 2023

Arterial Pouch Microsurgical Bifurcation Aneurysm Model in the Rabbit
06:11

Arterial Pouch Microsurgical Bifurcation Aneurysm Model in the Rabbit

Published on: May 14, 2020

Related Experiment Videos

Last Updated: May 16, 2026

A New Murine Model of Endovascular Aortic Aneurysm Repair
08:51

A New Murine Model of Endovascular Aortic Aneurysm Repair

Published on: July 7, 2013

Microsurgical Creation of Giant Bifurcation Aneurysms in Rabbits for the Evaluation of Endovascular Devices
07:21

Microsurgical Creation of Giant Bifurcation Aneurysms in Rabbits for the Evaluation of Endovascular Devices

Published on: September 8, 2023

Arterial Pouch Microsurgical Bifurcation Aneurysm Model in the Rabbit
06:11

Arterial Pouch Microsurgical Bifurcation Aneurysm Model in the Rabbit

Published on: May 14, 2020

Area of Science:

  • Vascular Surgery
  • Abdominal Aortic Aneurysm Treatment
  • Inflammatory Conditions

Background:

  • Inflammatory abdominal aortic aneurysms (IAAA) present unique challenges in treatment.
  • Endovascular aneurysm repair (EVAR) is becoming a common approach for IAAA.
  • Concerns exist regarding the resolution of retroperitoneal inflammation after EVAR for IAAA.

Purpose of the Study:

  • To evaluate the efficacy and outcomes of EVAR in treating IAAA.
  • To address concerns about post-operative inflammation following EVAR for IAAA.
  • To support the use of EVAR as a treatment option for IAAA.

Main Methods:

  • Review of a recent experience treating 69 IAAA cases.
  • Comparison of outcomes between open and endovascular repair methods.
  • Discussion of existing literature on EVAR for IAAA.

Main Results:

  • The study presents results supporting the use of EVAR for IAAA.
  • Experience with 69 IAAA cases treated by both open and endovascular methods.
  • EVAR demonstrated positive outcomes in the management of IAAA.

Conclusions:

  • EVAR is a viable and effective treatment for inflammatory abdominal aortic aneurysms.
  • The results support the continued application of EVAR for IAAA.
  • Further discussion of EVAR in IAAA treatment is warranted.